Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease
Gut and Liver · 2024
DOI: 10.5009/gnl230022 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Gut and Liver, 2024. Verfasst von Yoo Min Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea. Hauptthemen laut MEDLINE: Infliximab, Leukocyte L1 Antigen Complex, Crohn Disease, Feces. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Soonchunhyang University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
- Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Korea.
- Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD), Daegu, Korea.
- Department of Pediatrics, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
- Department of Pediatrics, Ajou University Medical Center, Suwon, Korea.
ORCID-Profile: Yoo Min Lee, Eun Sil Kim, Sujin Choi, Hyo-Jeong Jang, Yu Bin Kim, So Yoon Choi, Byung-Ho Choe, Ben Kang
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Soonchunhyang University
Zitieren
APA
Lee, Y. M., Kim, E. S., Choi, S., Jang, H. J., Kim, Y. B., Choi, S. Y., Choe, B. H., & Kang, B. (2024). Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease. Gut and Liver. https://doi.org/10.5009/gnl230022
Vancouver
Lee YM, Kim ES, Choi S, Jang HJ, Kim YB, Choi SY, et al. Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease. Gut and Liver. 2024. doi:10.5009/gnl230022
BibTeX
@article{Lee2024,
author = {Lee, Yoo Min and Kim, Eun Sil and Choi, Sujin and Jang, Hyo-Jeong and Kim, Yu Bin and Choi, So Yoon and Choe, Byung-Ho and Kang, Ben},
title = {Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease},
journal = {Gut and Liver},
year = {2024},
doi = {10.5009/gnl230022}
}
EUVIMED